Shareholders Equity: The sum of preferred and common equity items.
Minerva Neurosciences, Inc (NERV) had Shareholders Equity of $-29.15M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.75M |
|
-- |
|
-- |
|
$3.90M |
|
$-3.90M |
|
$0.15M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.75M |
|
$-3.90M |
|
$-3.90M |
|
7.57M |
|
7.57M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$17.92M |
|
$0.00M |
|
$14.87M |
|
$32.80M |
|
$1.95M |
|
-- |
|
$60.00M |
|
$61.95M |
|
$-29.15M |
|
$-44.02M |
|
|
Shareholders Equity |
$-29.15M |
6.99M |
|
| Cash Flow Statement Financials | |
$-4.07M |
|
-- |
|
-- |
|
$21.46M |
|
$17.39M |
|
$-4.07M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.88% |
|
8.53% |
|
-11.44% |
|
12.88% |
|
$-4.17 |
|
$-0.54 |
|
$-0.54 |
|